A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US

Abroad (travel likely)Recruiting

Conditions

Immunoglobulin A Nephropathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Novartis Investigational site, Boston, Massachusetts, United States

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

Primary Immunoglobulin A Nephropathy (IgAN)

IsraelRecruitingPHASE3

Aurora, United States · Philadelphia, United States

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

Glomerulonephritis, IGA · Immunoglobulin A Nephropathy

IsraelRecruitingPHASE2

Birmingham, United States · Los Angeles, United States

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

Immunoglobulin A Nephropathy (IgAN)

Abroad (travel likely)RecruitingPHASE3

Little Rock, United States · Apple Valley, United States

Chinese Adults With Kidney Disease

Immunoglobulin A Nephropathy (IgAN) · Complement 3 Glomerulopathy (C3G) · IC-MPGN

Abroad (travel likely)RecruitingPHASE2

Shenzhen, China · Guiyang, China